Cerus (CERS) Cash & Current Investments (2010 - 2026)
Cerus (CERS) reported Cash & Current Investments of $80.4 million for Q1 2026, down 0.61% on a YoY basis from $80.9 million in Q1 2025, and down 2.96% sequentially from $82.9 million in Q4 2025.
Cerus (CERS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Cash & Current Investments data on file, last reported at $80.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 0.61% year-over-year to $80.4 million; the trailing twelve-month figure through Mar 2026 stood at $80.4 million (down 0.61% YoY), and the FY2025 full-year result was $82.9 million, up 3.02% from the prior year.
- Cash & Current Investments slipped to $80.4 million in Q1 2026, from $82.9 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $108.6 million in Q1 2022 to a low of $65.9 million in Q4 2023.
- A 5-year average of $85.0 million and a median of $80.5 million in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments tumbled 35.54% in 2023 and advanced 22.17% in 2024, its largest moves.
- Tracing CERS's Cash & Current Investments over 5 years: stood at $102.2 million in 2022, then plunged by 35.54% to $65.9 million in 2023, then climbed by 22.17% to $80.5 million in 2024, then advanced by 3.02% to $82.9 million in 2025, then dropped by 2.96% to $80.4 million in 2026.
- Business Quant data shows CERS's Cash & Current Investments at $80.4 million in Q1 2026, $82.9 million in Q4 2025, and $78.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 80.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.43 Mn |
| Dec 31, 2025 | 82.88 Mn |
| Sep 30, 2025 | 78.51 Mn |
| Jun 30, 2025 | 78.03 Mn |
| Mar 31, 2025 | 80.92 Mn |
| Dec 31, 2024 | 80.45 Mn |
| Sep 30, 2024 | 75.57 Mn |
| Jun 30, 2024 | 71.19 Mn |
| Mar 31, 2024 | 72.18 Mn |
| Dec 31, 2023 | 65.85 Mn |
| Sep 30, 2023 | 79.01 Mn |
| Jun 30, 2023 | 84.50 Mn |
| Mar 31, 2023 | 94.68 Mn |
| Dec 31, 2022 | 102.15 Mn |
| Sep 30, 2022 | 103.83 Mn |
| Jun 30, 2022 | 107.05 Mn |
| Mar 31, 2022 | 108.56 Mn |
| Dec 31, 2021 | 129.36 Mn |
| Sep 30, 2021 | 119.96 Mn |
| Jun 30, 2021 | 122.84 Mn |